Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Galapagos reports 24-week data from the phase IIb DARWIN 2 trial

Aug. 12, 2015

Enrollment begins in U.S. phase III trial of ECCS-50

Aug. 7, 2015

Filgotinib meets key efficacy endpoints in phase IIb DARWIN 1 study

Aug. 3, 2015

Aurigene Discovery discloses RORgamma receptor ligands

July 29, 2015

FDA approves Dysport for upper limb spasticity

July 17, 2015

Tunable BTK inhibitors from Principia Biopharma show promise for autoimmune diseases

July 17, 2015

BTK inhibitors described in Merck & Co. patent

July 16, 2015

Seattle Genetics begins Adcetris trial in systemic lupus erythematosus

July 10, 2015

Anika Therapeutics reports data from follow-up study of Cingal

July 10, 2015

Novel BTK inhibitor shows potential for the treatment of RA

July 10, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...